Close menu
Brain & Behavior
Grants & Prizes
Home
Research
Illness
Addiction
Anxiety Disorders
Attention-Deficit Hyperactivity Disorder (ADHD)
Autism Spectrum Disorder (ASD)
Bipolar Disorder
Borderline Personality Disorder (BPD)
Depression
Eating Disorders
Mental Illness (General)
Obsessive-Compulsive Disorder (OCD)
Post-Traumatic Stress Disorder (PTSD)
Schizophrenia
Suicide Prevention
Other Brain-Related Illnesses
Category
Basic Research
New Technologies
Early Intervention/ Diagnostic Tools
Next Generation Therapies
Blog
Get Involved
Give
Donate Today
Make a Memorial/Tribute Gift
Create an Event/Memorial Page
Find an Event/Memorial Page
Make a Stock/Securities Gift/IRA Charitable Rollover Gift
Donate Cryptocurrency
Get Involved
Other Giving Opportunities
Planned Giving
Research Partners
Donor Advised Funds
Workplace Giving
Team Up for Research!
Sponsorship Opportunities
Watch
Healthy Minds TV
Meet the Scientist Webinars
Videos
Connect
Ask the Expert
Join Us
Home
Grants
Grant FAQs
BBRF Young Investigator Grants
BBRF Independent Investigator Grants
BBRF Distinguished Investigator Grants
Prizes & Awards
Klerman & Freedman Prizes
Outstanding Achievement Prizes
Lieber Prize for Schizophrenia Research
Maltz Prize for Schizophrenia Research
Colvin Prize for Mood Disorders Research
Ruane Prize for Child and Adolescent Psychiatric Research
Goldman-Rakic Prize for Cognitive Neuroscience Research
The Pardes Humanitarian Prize
Productive Lives Awards
Blog
About Us
Who We Are
Our Impact
FAQs
Media Center
News
Press Releases
Opinion Pieces
In the News
Multimedia Library
Media Kit
Events & Webinars
Team Up for Research! Events
Healthy Minds TV
Contact
Email Signup
Open Menu

Menu

Next-Generation Therapies

Next-Generation Therapies

We invest in next-generation therapies to reduce symptoms of mental illness and ultimately prevent and cure brain and behavior disorders.

Discovery Articles

Stem Cell Technology Helps Identify a Potential Casual Mechanism in Schizophrenia That Could Be Targeted

READ

Posted: Thursday, May 5, 2022

Stem Cell Technology Helps Identify a Potential Casual Mechanism in Schizophrenia That Could Be Targeted

Read more
New Insights About Epilepsy Mechanism Suggest a Potential Treatment Target

READ

Posted: Thursday, April 28, 2022

New Insights About Epilepsy Mechanism Suggest a Potential Treatment Target

Read more
Team Tests Model to Enable More Effective Targeting of Non-Invasive TMS Treatments in Depression

READ

Posted: Thursday, April 21, 2022

Team Tests Model to Enable More Effective Targeting of Non-Invasive TMS Treatments in Depression

Read more
Imaging Analysis Suggests How Ketamine Treatment Might Have Helped Reduce Chronic PTSD Symptoms in Trial Subjects

READ

Posted: Thursday, April 14, 2022

Imaging Analysis Suggests How Ketamine Treatment Might Have Helped Reduce Chronic PTSD Symptoms in Trial Subjects

Read more
Team Uses Non-Invasive TMS Brain Stimulation to Activate Deep-Brain Region Important in Depression

READ

Posted: Thursday, April 7, 2022

Team Uses Non-Invasive TMS Brain Stimulation to Activate Deep-Brain Region Important in Depression

Read more
Adding Lithium Might Enable Ketamine's Antidepressant Activity in Ketamine-Resistant Patients, Study Suggests

READ

Posted: Thursday, March 3, 2022

Adding Lithium Might Enable Ketamine's Antidepressant Activity in Ketamine-Resistant Patients, Study Suggests

Read more
Discovering How tDCS Brain Stimulation Therapeutically Modifies Brain Circuits in Depression

READ

Posted: Thursday, February 17, 2022

Discovering How tDCS Brain Stimulation Therapeutically Modifies Brain Circuits in Depression

Read more
Evidence That Cognitive Behavioral Therapy Can Help People With Insomnia Who Also Are Depressed or Anxious

READ

Posted: Thursday, February 10, 2022

Evidence That Cognitive Behavioral Therapy Can Help People With Insomnia Who Also Are Depressed or Anxious

Read more
In Pilot Study, Oxygen Therapy for Moderate Depression Showed Beneficial Effects

READ

Posted: Thursday, January 6, 2022

In Pilot Study, Oxygen Therapy for Moderate Depression Showed Beneficial Effects

Read more
Two Signaling Pathways Involved in Regulating Synaptic Plasticity Suggest Novel Targets for Rapid-Acting Antidepressants

READ

Posted: Thursday, December 2, 2021

Two Signaling Pathways Involved in Regulating Synaptic Plasticity Suggest Novel Targets for Rapid-Acting Antidepressants

Read more
Non-Invasive Brain-Stimulation Protocol for Treatment-Resistant Depression Enabled 79% to Experience Remission Following 5-Day Treatment Course

READ

Posted: Thursday, November 11, 2021

Non-Invasive Brain-Stimulation Protocol for Treatment-Resistant Depression Enabled 79% to Experience Remission Following 5-Day Treatment Course

Read more
Lumateperone, an Antipsychotic, is Tested in a Phase 3 Trial for Major Depressive Episodes in Bipolar I and II Disorders

READ

Posted: Thursday, November 4, 2021

Lumateperone, an Antipsychotic, is Tested in a Phase 3 Trial for Major Depressive Episodes in Bipolar I and II Disorders

Read more
Positive Preliminary Results in Highly Personalized Deep-Brain Stimulation Therapy for Treatment-Resistant Depression

READ

Posted: Thursday, October 28, 2021

Positive Preliminary Results in Highly Personalized Deep-Brain Stimulation Therapy for Treatment-Resistant Depression

Read more
Mindfulness Training Plus tDCS Stimulation to Treat Cognitive Decline in Older Persons with Depression or Anxiety

READ

Posted: Thursday, October 21, 2021

Mindfulness Training Plus tDCS Stimulation to Treat Cognitive Decline in Older Persons with Depression or Anxiety

Read more
New Treatment Approach for Alcohol Use Disorder is Tested in Animals

READ

Posted: Thursday, October 14, 2021

New Treatment Approach for Alcohol Use Disorder is Tested in Animals

Read more
Study Indicates Brain Lesions and Treatment Targets in Depression Affect the Same Circuitry, Suggesting New Treatment Possibilities

READ

Posted: Thursday, August 5, 2021

Study Indicates Brain Lesions and Treatment Targets in Depression Affect the Same Circuitry, Suggesting New Treatment Possibilities

Read more
Positive Phase 3 Test of Rapid-Acting Oral Medicine for Postpartum Depression

READ

Posted: Wednesday, July 14, 2021

Positive Phase 3 Test of Rapid-Acting Oral Medicine for Postpartum Depression

Read more
Study Links Schizophrenia Medicines’ Anticholinergic Impact to Risk of Cognitive Impairment

READ

Posted: Thursday, July 1, 2021

Study Links Schizophrenia Medicines’ Anticholinergic Impact to Risk of Cognitive Impairment

Read more
Positive Results in Trial Testing ‘Laughing Gas’ in Severely Depressed Treatment-Resistant Patients

READ

Posted: Thursday, June 17, 2021

Positive Results in Trial Testing ‘Laughing Gas’ in Severely Depressed Treatment-Resistant Patients

Read more
Postpartum CBT for Depressed Moms May Help Lower Emotion-Regulation Risks in Infants

READ

Posted: Thursday, June 10, 2021

Postpartum CBT for Depressed Moms May Help Lower Emotion-Regulation Risks in Infants

Read more
Experiments in Rodents Suggest Feasibility of Modifying or Erasing Traumatic Fear Memories

READ

Posted: Thursday, May 13, 2021

Experiments in Rodents Suggest Feasibility of Modifying or Erasing Traumatic Fear Memories

Read more
Medicine to Treat Premenstrual Mood Disorder is Tested

READ

Posted: Thursday, May 6, 2021

Medicine to Treat Premenstrual Mood Disorder is Tested

Read more
In Early Schizophrenia, Long-Acting Injectable Antipsychotic Treatment Lengthened Time to First Hospitalization

READ

Posted: Thursday, March 25, 2021

In Early Schizophrenia, Long-Acting Injectable Antipsychotic Treatment Lengthened Time to First Hospitalization

Read more
In Major Depression, Accelerated rTMS Brain Stimulation Shows Promise

READ

Posted: Thursday, March 11, 2021

In Major Depression, Accelerated rTMS Brain Stimulation Shows Promise

Read more
Brain-Wave Patterns Shed Light on Pathologies and New Treatments in Substance-Use Disorders

READ

Posted: Thursday, March 4, 2021

Brain-Wave Patterns Shed Light on Pathologies and New Treatments in Substance-Use Disorders

Read more
Researchers Explore Whether L-DOPA Can Help PTSD Patients Learn to Extinguish Fear Memories

READ

Posted: Wednesday, February 24, 2021

Researchers Explore Whether L-DOPA Can Help PTSD Patients Learn to Extinguish Fear Memories

Read more
In Schizophrenia, Differences in the Brain’s Energy Pathways Suggest Possible New Treatment Target

READ

Posted: Thursday, February 18, 2021

In Schizophrenia, Differences in the Brain’s Energy Pathways Suggest Possible New Treatment Target

Read more
Combining the Antipsychotic Olanzapine with an Opioid-Receptor Blocker Significantly Limited Weight-Gain Risk in Schizophrenia Patients

READ

Posted: Thursday, January 28, 2021

Combining the Antipsychotic Olanzapine with an Opioid-Receptor Blocker Significantly Limited Weight-Gain Risk in Schizophrenia Patients

Read more
Repeated Ketamine Infusions Over 2 Weeks Significantly Reduced Chronic PTSD Symptoms

READ

Posted: Thursday, January 14, 2021

Repeated Ketamine Infusions Over 2 Weeks Significantly Reduced Chronic PTSD Symptoms

Read more
Psychosocial Interventions Are Found to Reduce Inflammation and Boost Beneficial Immune System Function

READ

Posted: Thursday, January 7, 2021

Psychosocial Interventions Are Found to Reduce Inflammation and Boost Beneficial Immune System Function

Read more
Psychotherapy in Addition to Medication Helps Bipolar Disorder Patients Avoid Relapse and Manage Their Symptoms, Study Determines

READ

Posted: Thursday, November 19, 2020

Psychotherapy in Addition to Medication Helps Bipolar Disorder Patients Avoid Relapse and Manage Their Symptoms, Study Determines

Read more
Unconscious Exposure to a Feared Stimulus Can Reduce Fear, Study Shows

READ

Posted: Thursday, November 5, 2020

Unconscious Exposure to a Feared Stimulus Can Reduce Fear, Study Shows

Read more
More Articles

grants-logo.png

View All Foundation Grantees

Sort listing by name, grant type, year, illness, or institution (at time of most recent Grant).

View Our Grantee Listing